Archive ready

自主回収|クラス1|報道発表資料|厚生労働省

https://www.mhlw.go.jp/stf/newpage_08207.html
April 3, 2026 at 09:30 PM JSTThe archive page, viewer, and downloads use this saved version.
April 3, 2026 at 09:30 PM JST·www.mhlw.go.jp

自主回収|クラス1|報道発表資料|厚生労働省

Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.

StartedApril 3, 2026 at 09:30 PM JST

This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.

The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.

About this pageAI generated

This page is a press release from Japan's Ministry of Health, Labour and Welfare regarding a drug recall. Zeria Novo Corporation has initiated a voluntary recall of the pharmaceutical product with the general name "Japanese Pharmacopoeia Nizatidine" and brand name "Acsinon Tablet 75mg." The affected lots include A71, B72, B73, F714-F719, G720, E812-E814, and J825. Released on December 3, 2019, the document provides contact information from relevant divisions within the ministry's Pharmaceutical and Medical Devices Agency.

自主回収|クラス1|報道発表資料|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.